Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288
Author Contributions
Acknowledgments
Conflicts of Interest
Abbreviations
IBD | Inflammatory Bowel Disease |
NAFLD | Nonalcoholic Fatty Liver Disease |
MASLD | Metabolic Dysfunction-associated Steatotic Liver Disease |
References
- Rotaru, A.; Stafie, R.; Stratina, E.; Zenovia, S.; Nastasa, R.; Minea, H.; Huiban, L.; Cuciureanu, T.; Muzica, C.; Chiriac, S.; et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288. [Google Scholar] [CrossRef] [PubMed]
- Hong, S.; Sun, L.; Hao, Y.; Li, P.; Zhou, Y.; Liang, X.; Hu, J.; Wei, H. From NAFLD to MASLD: When metabolic comorbidity matters. Ann. Hepatol. 2024, 29, 101281. [Google Scholar] [CrossRef] [PubMed]
- Sato-Espinoza, K.; Chotiprasidhi, P.; Huaman, M.R.; Díaz-Ferrer, J. Update in lean metabolic dysfunction-associated steatotic liver disease. World J. Hepatol. 2024, 16, 452–464. [Google Scholar] [PubMed]
- Scarlata, G.G.M.; Abenavoli, L. Gut microbiota: The pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease. Expert Rev. Gastroenterol. Hepatol. 2025, 19, 85–88. [Google Scholar] [CrossRef] [PubMed]
- Cicchinelli, S.; Gemma, S.; Pignataro, G.; Piccioni, A.; Ojetti, V.; Gasbarrini, A.; Franceschi, F.; Candelli, M. Intestinal Fibrogenesis in Inflammatory Bowel Diseases: Exploring the Potential Role of Gut Microbiota Metabolites as Modulators. Pharmaceuticals 2024, 17, 490. [Google Scholar] [CrossRef] [PubMed]
- Lai, J.; Luo, L.; Zhou, T.; Feng, X.; Ye, J.; Zhong, B. Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis. Biomolecules 2023, 13, 1356. [Google Scholar] [CrossRef] [PubMed]
- Rinella, M.E.; Lazarus, J.V.; Ratziu, V.; Francque, S.M.; Sanyal, A.J.; Kanwal, F.; Romero, D.; Abdelmalek, M.F.; Anstee, Q.M.; Arab, J.P.; et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023, 78, 1966–1986. [Google Scholar] [CrossRef] [PubMed]
- Rahmani, J.; Kord-Varkaneh, H.; Hekmatdoost, A.; Thompson, J.; Clark, C.; Salehisahlabadi, A.; Day, A.S.; Jacobson, K. Body mass index and risk of inflammatory bowel disease: A systematic review and dose-response meta-analysis of cohort studies of over a million participants. Obes. Rev. 2019, 20, 1312–1320. [Google Scholar] [CrossRef] [PubMed]
- Danpanichkul, P.; Suparan, K.; Kim, D.; Wijarnpreecha, K. What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside. J. Clin. Med. 2024, 13, 278. [Google Scholar] [CrossRef] [PubMed]
- Abenavoli, L.; Spagnuolo, R.; Scarlata, G.G.M.; Gambardella, M.L.; Boccuto, L.; Méndez-Sánchez, N.; Luzza, F. Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study. Life 2024, 14, 1226. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Scarlata, G.G.M.; Abenavoli, L. Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288. Life 2025, 15, 1210. https://doi.org/10.3390/life15081210
Scarlata GGM, Abenavoli L. Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288. Life. 2025; 15(8):1210. https://doi.org/10.3390/life15081210
Chicago/Turabian StyleScarlata, Giuseppe Guido Maria, and Ludovico Abenavoli. 2025. "Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288" Life 15, no. 8: 1210. https://doi.org/10.3390/life15081210
APA StyleScarlata, G. G. M., & Abenavoli, L. (2025). Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288. Life, 15(8), 1210. https://doi.org/10.3390/life15081210